Foshan First People's Hospital

Foshan 528010

0 studies enrolling now · 2 studies all time

What they study most

Atherosclerotic Cardiovascular Disease, Carcinoma, Non-Small-Cell Lung, Dyslipidemias, Familial Hypercholesterolemia, High Cholesterol, Hypercholesterolemia

Studies at this site

• Randomized Study to Evaluate the Effect of Obicetrapib on Top of Maximum Tolerated Lipid-Modifying Therapies — Completed
• A Study of Tislelizumab (BGB-A317) Plus Chemoradiotherapy Followed by Tislelizumab Monotherapy in Newly Diagnosed, Stage III Subjects With Locally Advanced, Unresectable Non-small Cell Lung Cancer — Stopped early